细胞凋亡
克隆形成试验
PI3K/AKT/mTOR通路
化学
蛋白激酶B
癌症研究
药理学
细胞生长
依托泊苷
细胞培养
标记法
木犀草素
信号转导
化疗增敏剂
联合疗法
半胱氨酸蛋白酶3
毒性
污渍
半胱氨酸蛋白酶8
细胞毒性
细胞
阿霉素
半胱氨酸蛋白酶
作者
Weilin Huang,Feng Liang,Hui Xu,Rong Zhang,Mingyi Zhao,Ting Sun
标识
DOI:10.2174/0118715206430858260313082444
摘要
Background: Etoposide (VP-16) is a widely used chemotherapeutic agent, but its efficacy is limited by toxicity and resistance. Luteolin (LUT), a natural flavonoid, exhibits antitumor activity and may enhance chemotherapy through signaling modulation. This study explores the synergistic effects of LUT and VP-16 and the underlying mechanism. Methods: The H22 and 4T1 mouse tumor cells, as well as the human hepatocellular carcinoma cell line Huh7, were treated with LUT, VP-16, or their combination. The cell viability, colony formation, and apoptosis were evaluated by CCK-8 assay, crystal violet staining, and TUNEL assay, and the synergistic effect was analyzed using the combination index. The involvement of the PI3K/AKT signaling pathway was detected by Western blotting, and the agonist rescue experiment was conducted for verification. Antitumor efficacy and systemic toxicity were further evaluated in a subcutaneous xenograft mouse model. results: LUT and VP-16 combination significantly inhibited cell proliferation and clonogenic potential while promoting apoptosis in both cell lines (P < 0.01), with synergy confirmed by combination index values < 1. Western blotting revealed that the combination markedly suppressed PI3K and AKT phosphorylation, effects reversed by 740 Y-P. In vivo, combination therapy produced the most significant reduction in tumor volume and weight, accompanied by enhanced apoptosis and reduced PI3K/AKT activation Results: LUT and VP-16 combination significantly inhibited proliferation and clonogenic potential while promoting apoptosis in all tested cell lines (P < 0.01). Western blotting showed suppression of PI3K and AKT phosphorylation, effects reversed by 740 Y-P. In vivo, the combination produced the strongest tumor reduction with enhanced apoptosis and reduced PI3K/AKT activation. Discussion: The synergistic effect of LUT and VP-16 is largely mediated by PI3K/AKT pathway inhibition, providing mechanistic insight into their combined antitumor action and suggesting a strategy to enhance chemotherapy efficacy. Conclusion: LUT enhances the antitumor efficacy of VP-16 by synergistically inhibiting the PI3K/AKT signaling pathway. This combination presents a promising therapeutic strategy for improving chemotherapy outcomes in solid tumors.
科研通智能强力驱动
Strongly Powered by AbleSci AI